Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Sanofi is a global healthcare company. Among their duties are researching disease causes, determining starting points for drug treatment, developing drugs, producing active ingredients, and delivering finished drugs and active ingredients. Specialists in vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare.

Oval Medical Technologies is a specialty pharmaceutical device company developing next generation autoinjectors.

Manufactures pharmaceuticals

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

ICU Medical connects patients and caregivers through safe, life-saving, life-enhancing medical devices. They provide clinicians around the world with innovative and cost-effective patient care solutions for unmet clinical needs. Their products help clinicians improve patient outcomes by minimizing bacterial ingress that can cause bloodstream infections and preventing exposure to infectious diseases or hazardous drugs. Our diverse product line includes needlefree vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, advanced sensor catheters, needlefree closed blood sampling systems, and innovative hemodynamic monitoring systems. These clinically-proven innovations are the result of a unique company culture, supported by visionary leaders and resourceful minds, united by the common desire to redefine the limits of patient and healthcare worker safety.

FUJIFILM Toyama Chemical Co. Ltd., a subsidiary of FUJIFILM Holdings Corp., is a Japanese company located in Tokyo that develops and manufactures radioactive medical supplies. It was founded in 1968. Misao Tsuda is currently the CEO of the firm. FUJIFILM Toyama Chemical Co. Ltd. was acquired by FUJIFILM Holdings Corp. from Daiichi Sankyo Co., Ltd. on October 01, 2006.

SHL Medical AG engages in the design, development, and manufacture of advanced drug delivery devices, as well as provides final assembly, labeling, and packaging services for pharma and biotech companies. Its products include autoinjectors, pen injectors, inhaler systems, pressure mattress systems, patient lifting slings, medical soft goods. The firm also offers design-to-build and contract manufacturing of products, such as laboratory handling equipment, neurosurgical devices, and industrial equipment. The company was founded by Roger Samuelsson and Martin Jelf in 1989 and is headquartered in Zug, Switzerland.

TotusRX , Inc. offers automated devices for pharmaceutical industry. It delivers a platform of automated stores, smart packaging and analytics to create the fundamental change in pharmaceutical dispensing and patient engagement. The firm through its devices reduce time to dispense medications and smart IoT (Internet of Things) centric packaging to monitor adherence. The company was founded by Kevin Michael Conlon and is headquartered in Longmont, CO.

EOFlow has launched EOPatch, the world’s smallest full-featured wearable, disposable insulin pump. EOPatch wearable insulin pump is smarter, better-connected, and lasts longer than the current market leader, yet costs less. The company will offer a software upgrade to enable closed-loop insulin control ('artificial pancreas' or 'automated insulin delivery') on the current system. It is also developing an all-in-one wearable disposable artificial pancreas solution, which was recently given a Breakthrough Device designation by FDA.

SHL Group AB develops, manufactures, and distributes advanced drug delivery devices. Its products include pen-injectors, auto-injectors, and inhaler systems. It also manufactures rehabilitation equipment for the hospital and home health care market. The company was founded by Roger Samuelsson in 1989 and is headquartered in Nacka Strand, Sweden.

Sanofi A/S engages in the production of prescription drugs as well as participates in clinical trials of present and future products. It specializes in diabetes, oncology, multiple sclerosis, rare disease and cardio vascular illnesses. The company is headquartered in Copenhagen, Denmark.

WatchRx was founded to help older adults with chronic health conditions manage their medications while giving caregivers and healthcare providers the ability to monitor remotely. WatchRx provides a simple, personalized and customizable smartwatch with a dedicated reminder solution, GPS, emergency alert, fall detection and predictive analytics. The smartwatch features include voice reminders, family member alerts, voice calls, GPS tracking, and alerts.

Pelago Bioscience AB is a private company headquartered in Solna, Sweden. The firm provides drug discovery research services through biologically relevant assay systems.

Kali monitoring technology integrates smart sensors, data analytics and cloud services. In clinical trials Kali system replaces assumption and self-reporting for medication adherence by collecting objective data and automatically integrating the data into study database resulting in shorter and more efficient clinical trial. In clinical practice Kali adherence score provides critical information for explaining the incongruity between recommended treatment and actual treatment outcomes. Kali clinical trial monitoring platform is currently deployed in twenty countries.

CareFusion 303, Inc. designs, makes and distributes infusion therapy and vital signs measurement instruments. The company operates manufacturing facilities in the United States, Mexico and the United Kingdom. The firm was founded in 1988 and is headquartered in San Diego, CA.

SHL Group Ltd. provides human resources consulting services. It provides psychologists for the administration and interpretation of tests. The company was founded in 1977 and is headquartered in Thames Ditton, the United Kingdom.

PHC Holdings Corp. engages in the development, manufacture, and sale of healthcare devices and services. It operates through the following segments: Diabetes Management, Healthcare Solutions, and Diagnosis and Life Science. The Diabetes Management segment deals with the development, manufacture, and sale of in-vitro diagnostic equipment such as self-monitoring blood glucose system, Point of Care Testing products, and electric drug injectors. The Healthcare Solutions segment develops and sells medical IT products such as receipt computers and electronic medical records, and conducts clinical laboratory diagnosis business. The Diagnosis and Life Science segment includes the development, manufacture and sale of research and medical support equipment, and pathological diagnosis equipment. The company was founded on August 13, 2013 and is headquartered in Tokyo, Japan.